Will Kailera Therapeutics’s market cap be greater than $2.1B at market close on IPO day?

1 smart money signal detected, totaling $1,414.

Categories: IPOs, Finance, Business, Tech, IPO, Rewards 300 4.5 50

Notable Trades

Sharp bettor in thin IPO market

A proven high-win-rate wallet bought into a thin IPO market at 58¢ before a quick move to 65%, making this small but notable sharp-money signal despite the low composite score.

  • This bettor wins 86% of resolved trades across 348 bets, which makes their moves worth tracking
  • They bought Yes at 58¢ in a market with only about $5.6k of liquidity, and the price is already up to 65¢
  • The trade was about 25% of recent volume, suggesting real conviction in a relatively thin IPO market

$1,414 on Yes | Wallet win rate: 86%

Top Holders

  1. 0xa5ef...2966 Outcome 71168549, $1,980
  2. 0x70c7...2c31 Outcome 71168549, $237
  3. 0xf629...bda0 Outcome 71168549, $200 (43% win rate)
  4. 0x66a1...80d9 Outcome 71168549, $200
  5. 0x0061...8fd6 Outcome 71168549, $200
  6. 0x7ab6...fa77 Outcome 71168549, $164
  7. 0x04db...f0fd Outcome 71168549, $144
  8. 0xf0b0...8cab Outcome 71168549, $60
  9. 0x3b7b...2d1a Outcome 59800238, $50
  10. 0xad53...ef24 Outcome 71168549, $39

Will Kailera Therapeutics’s market cap be greater than $2.1B at market close on IPO day?

Resolved$1,414 tracked1 signalIPOsFinanceBusinessTechIPORewards 300 4.5 50

This market will resolve based on Kailera Therapeutics’ market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page. If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket. The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading. In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.

Notable Trades

Will Kailera Therapeutics’s market cap be greater than $2.1B at market close on IPO day?

2d ago

$1,414 on Yes at 58¢